FDA mulls compounding for peptides previously flagged over safety risks BioSpace Is BPC 157 Legal? Understanding Its Status and Implications FDA's Legislative Request on Rx and Compounded Drug Advertising Coalition for Healthcare Communication In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Why would a patient trust a peptide more than a statin? STAT FDA's Overreach on Compounded Peptides